Streetbeat News

Analyst Ratings

VKTX

Truist Securities analyst Joon Lee has reiterated a Buy rating on Viking Therapeutics (NASDAQ:VKTX) and maintained a $32 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 1:35 pm

VRNA

Truist Securities analyst Joon Lee has reiterated a Buy rating on Verona Pharma (NASDAQ:VRNA) and maintained a $32 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 1:34 pm

UNH

Truist Securities analyst David Macdonald has reiterated a Buy rating on UnitedHealth Group (NYSE:UNH) and maintained a $580 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 1:33 pm

SLG

Truist Securities analyst Michael Lewis has reiterated a Buy rating on SL Green Realty (NYSE:SLG) and maintained a $50 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 1:32 pm

ACHR

Cantor Fitzgerald analyst Andres Sheppard reiterates an Overweight rating on Archer Aviation (NYSE:ACHR) and maintains a $10 price target.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 1:31 pm

REGN

Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on Regeneron Pharmaceuticals (NASDAQ:REGN) and maintained a $1050 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 1:31 pm

RRR

Truist Securities analyst Barry Jonas reiterated a Hold rating on Red Rock Resorts (NASDAQ:RRR) and maintained a $50 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 1:30 pm

PACW

Truist Securities analyst Brandon King has reiterated a Hold rating on PacWest Banc (NASDAQ:PACW) and maintained a $13 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 1:29 pm

PENN

Truist Securities analyst Barry Jonas reiterated a Buy rating on PENN Entertainment (NASDAQ:PENN) and maintained a $33 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 1:23 pm

OPCH

Truist Securities analyst David Macdonald reiterated a Buy rating on Option Care Health (NASDAQ:OPCH) and maintained a $39 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 1:22 pm